Mekrazym

Amylase, Lipase, and Protease, the active ingredients in Mekrazym, are a digestive enzyme supplement presented as an oral formulation for oral use. It supports the breakdown of carbohydrates, fats and proteins in individuals with enzyme deficiency or malabsorption.

GNH USA supplies Mekrazym as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mekrazym provides exogenous digestive enzymes to aid nutrient breakdown in conditions where endogenous production is insufficient. - Exocrine pancreatic insufficiency: improves digestion and nutrient absorption. - Cystic fibrosis‑related malabsorption: enhances fat and protein utilization. - Chronic pancreatitis: reduces steatorrhea and abdominal discomfort. - Post‑surgical pancreatic resection: supports recovery of digestive function.

Adverse reactions may occur with any oral enzyme supplement.

Common Side Effects: - Mild abdominal discomfort or bloating. - Flatulence or increased gas production. - Nausea or transient loss of appetite. - Soft stools or mild diarrhea. - Unpleasant taste or after‑taste.

Serious or Rare Side Effects: - Allergic reaction such as rash, itching, swelling, or anaphylaxis. - Severe abdominal pain with vomiting. - Persistent or worsening diarrhea leading to dehydration. - Pancreatitis flare in susceptible individuals. - Unexplained weight loss despite adequate intake.

Mekrazym should be used with awareness of specific safety considerations. - Assess pancreatic function: confirm enzyme deficiency before initiating therapy. - Monitor for allergic reactions: discontinue if signs of hypersensitivity appear. - Adjust dose in renal or hepatic impairment only under medical guidance. - Avoid concomitant use with antacids that may inactivate enzymes unless advised. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Enzyme supplements can interact with certain medications and foods.

Major Interactions (Avoid): - Proton pump inhibitors or high‑dose antacids: may reduce enzyme activity. - Certain antibiotics (e.g., tetracycline): can bind to enzymes and diminish effectiveness.

Moderate Interactions (Monitor Closely): - Warfarin: monitor INR as altered vitamin K absorption may affect anticoagulation. - Oral contraceptives: observe for changes in hormone levels due to altered gut absorption. - Fat‑soluble vitamins (A, D, E, K): consider supplementation if deficiency is suspected.